SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-800538
Filing Date
2016-12-21
Accepted
2016-12-21 16:35:03
Documents
4
Period of Report
2016-12-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d275602d8k.htm 8-K 27996
2 EX-3.1 d275602dex31.htm EX-3.1 85751
3 EX-99.1 d275602dex991.htm EX-99.1 8496
4 GRAPHIC g275602g29a39.gif GRAPHIC 4753
  Complete submission text file 0001193125-16-800538.txt   130216
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 162064282
SIC: 2834 Pharmaceutical Preparations